Filtered By:
Specialty: Pharmaceuticals
This page shows you your search results in order of date. This is page number 17.
Order by Relevance | Date
Total 6905 results found since Jan 2013.
How Strength Training Can Help Post-Covid Recovery
Strength training has some distinct advantages when resuming an exercise routine after a Covid-19 infection.
Source: Forbes.com Healthcare News - October 27, 2022 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation Coronavirus business pharma & Source Type: news
Overall Symptoms After BNT162b2, Other Vaccines Comparable in
THURSDAY, Oct. 27, 2022 -- Among children younger than 5 years, guardian-reported symptoms after BNT162b2 administration were generally comparable to those for on-label non-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines,...
Source: Drugs.com - Pharma News - October 27, 2022 Category: Pharmaceuticals Source Type: news
As Tuberculosis Burden Increases Due To Covid-19, WHO Calls For Urgent Action
The 2022 Global Tuberculosis Report, released today by WHO, shows that the Covid-19 pandemic has reversed years of progress in controlling TB. For the first time in many years, TB deaths and TB incidence have increased.
Source: Forbes.com Healthcare News - October 27, 2022 Category: Pharmaceuticals Authors: Madhukar Pai, Contributor Tags: Healthcare /healthcare Innovation /innovation Coronavirus Editors' Pick editors-pick Source Type: news
Cases of drug-resistant tuberculosis rise for first time in almost 20 years
WHO report highlights global resurgence of the disease during coronavirus pandemic
Source: FT.com - Drugs and Healthcare - October 27, 2022 Category: Pharmaceuticals Source Type: news
Overall Symptoms After BNT162b2 and Other Vaccines Comparable
THURSDAY, Oct. 27, 2022 -- Among children younger than 5 years, guardian-reported symptoms after BNT162b2 administration were generally comparable to those for on-label non-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines,...
Source: Drugs.com - Pharma News - October 27, 2022 Category: Pharmaceuticals Source Type: news
Covid Hospitalizations Climb Again As Another U.S. Wave Looms Large —These States Lead The Way
Around 2,500 people are dying with Covid each week as cases rise rapidly in some states and hospitalizations climb after weeks of decline.
Source: Forbes.com Healthcare News - October 27, 2022 Category: Pharmaceuticals Authors: Robert Hart, Forbes Staff Tags: Business /business Innovation /innovation Healthcare /healthcare Breaking breaking-news Dashboard Coronavirus Source Type: news
InnovationRx: Respiratory Diseases Surge, Covid ’s Connection To Heart Attacks And Genomics 3.0
InnovationRx is your weekly digest of healthcare news. Sign up!
Source: Forbes.com Healthcare News - October 27, 2022 Category: Pharmaceuticals Authors: Alex Knapp, Forbes Staff Tags: Innovation /innovation Healthcare /healthcare Science /science Venture Capital /venture-capital Coronavirus Editors' Pick editors-pick Newsletter No Paywall no-paywall Source Type: news
As Protection From Current Covid-19 Monoclonal Antibody Treatments Fades, The Discovery Of A New Class Of Antibodies Brings Hope
New classes of antibodies may be one of our best tools to overcome new immune evasive variants.
Source: Forbes.com Healthcare News - October 26, 2022 Category: Pharmaceuticals Authors: William A. Haseltine, Contributor Tags: Healthcare /healthcare Innovation /innovation Coronavirus business pharma & Source Type: news
What ’s Driving The Covid-19 Vaccine Price Increases?
Welcome to the convoluted world of U.S. healthcare. In the height of the pandemic, the government negotiated directly with the drug companies – no list price/net price worries, no middlemen – and everyone could get vaccinated for free. Now we are back to business as usual.
Source: Forbes.com Healthcare News - October 26, 2022 Category: Pharmaceuticals Authors: John LaMattina, Contributor Tags: Healthcare /healthcare Innovation /innovation Coronavirus business pharma Source Type: news
Roche receives FDA clearance for COVID-19 PCR test for use on cobas 6800/8800 Systems
The cobas SARS-CoV-2 Qualitative test is one of the first COVID-19 PCR tests performed on an automated, high throughput platform to receive FDA 510(k) clearance.This FDA clearance will ensure that the healthcare community has access to timely, reliable and accurate COVID-19 PCR testing beyond the EUA period.Based on continuous analysis performed since the onset of the pandemic, all Roche molecular tests, including the cobas SARS-CoV-2 Qualitative test, detect all SARS-CoV-2 variants. Basel, 24 October 2022 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has granted...
Source: Roche Investor Update - October 24, 2022 Category: Pharmaceuticals Source Type: news
Rates of Health Care Use Higher After Positive SARS-CoV-2 Test
FRIDAY, Oct. 21, 2022 -- The rates of health care use are significantly higher after a positive severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) test than after a negative test, according to a study published online Oct. 17 in CMAJ, the...
Source: Drugs.com - Pharma News - October 21, 2022 Category: Pharmaceuticals Source Type: news
InnovationRx: Zombie Mushrooms, Europe ’s Covid Wave And Soft Brain Implants
InnovationRx is your weekly digest of healthcare news. Sign up!
Source: Forbes.com Healthcare News - October 19, 2022 Category: Pharmaceuticals Authors: Alex Knapp, Forbes Staff Tags: Innovation /innovation Healthcare /healthcare Science /science Coronavirus Editors' Pick editors-pick Source Type: news
Word of the Month: What is Long COVID?
What is Long COVID?
Source: The Catalyst - October 19, 2022 Category: Pharmaceuticals Authors: Mike Ybarra Tags: Vaccines Coronavirus Source Type: news
Word of the Month: Long COVID
What is Long COVID?
Source: The Catalyst - October 19, 2022 Category: Pharmaceuticals Authors: Mike Ybarra Tags: Vaccines Coronavirus Word of the Month Source Type: news
